Zurich Cantonal Bank
TARO

Zurich Cantonal Bank’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Zurich Cantonal Bank’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-986
Closed -$41.7K – 2734
2024
Q1 		$41.7K Buy
+986
New +$41.5K ﹤0.01% 2582
2017
Q4 		– Sell
-3,922
Closed -$442K – 2571
2017
Q3 		$442K Hold
3,922
– – ﹤0.01% 871
2017
Q2 		$439K Sell
3,922
-546
-12% -$61.7K ﹤0.01% 863
2017
Q1 		$521K Buy
4,468
+768
+21% +$85K 0.01% 860
2016
Q4 		$389K Buy
3,700
+110
+3% +$11.5K ﹤0.01% 880
2016
Q3 		$397K Buy
3,590
+942
+36% +$125K ﹤0.01% 874
2016
Q2 		$386K Buy
2,648
+1,116
+73% +$158K 0.01% 857
2016
Q1 		$219K Buy
1,532
+1,107
+260% +$157K ﹤0.01% 919
2015
Q4 		$66K Buy
+425
New +$62K ﹤0.01% 1306

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Zurich Cantonal Bank's TARO Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 986 shares — an estimated $41.7K sold.

Zurich Cantonal Bank first reported a position in TARO in Q4 2015 and held it in 9 quarters. The position peaked at $521K in Q1 2017. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Zurich Cantonal Bank reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 986 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $41.7K.
  • Zurich Cantonal Bank first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 9 quarters.
  • Zurich Cantonal Bank's Taro Pharmaceutical Industries Ltd. position peaked at $521K in Q1 2017.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.